Search

everythinglearnresearchcommunity

for

Search:↓

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Recognizing minor skin lesions can help identify serious cancer syndromes.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

Histopathology is crucial for accurately diagnosing and predicting outcomes of skin adnexal tumors.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Melatonin may inhibit melanoma growth and has potential as a cancer therapy aid, but its effects on human skin pigmentation need more research.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

Head and neck melanoma cases rose by 51.1% in young males aged 15-39 from 1995 to 2014.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Recognizing specific scalp patterns can help diagnose hair loss linked to breast cancer spread.

Melanin-rich skin has unique challenges in diagnosing and treating skin diseases.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

Finasteride and dutasteride might lower melanoma risk.

The document updated knowledge on skin disorders, focusing on unusual moles in older adults, the progression from moles to melanoma, and evolving hair loss treatments.

Melanocyte stem cells can become melanoma, resembling human melanoma.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Vascular patterns in dermoscopy help tell apart malignant and benign skin tumors.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

Some skin conditions in pets can signal cancer or may develop into cancer, and monitoring or treating these can help detect or manage the disease.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

A man with nevus comedonicus syndrome had multiple skin issues, including basal cell carcinomas, which improved with treatment.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.